PMID- 20399149 OWN - NLM STAT- MEDLINE DCOM- 20100601 LR - 20230131 IS - 1878-3686 (Electronic) IS - 1535-6108 (Print) IS - 1535-6108 (Linking) VI - 17 IP - 5 DP - 2010 May 18 TI - Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. PG - 510-22 LID - 10.1016/j.ccr.2010.03.017 [doi] AB - We have profiled promoter DNA methylation alterations in 272 glioblastoma tumors in the context of The Cancer Genome Atlas (TCGA). We found that a distinct subset of samples displays concerted hypermethylation at a large number of loci, indicating the existence of a glioma-CpG island methylator phenotype (G-CIMP). We validated G-CIMP in a set of non-TCGA glioblastomas and low-grade gliomas. G-CIMP tumors belong to the proneural subgroup, are more prevalent among lower-grade gliomas, display distinct copy-number alterations, and are tightly associated with IDH1 somatic mutations. Patients with G-CIMP tumors are younger at the time of diagnosis and experience significantly improved outcome. These findings identify G-CIMP as a distinct subset of human gliomas on molecular and clinical grounds. CI - (c) 2010 Elsevier Inc. All rights reserved. FAU - Noushmehr, Houtan AU - Noushmehr H AD - USC Epigenome Center, University of Southern California, Los Angeles, CA 90033, USA. FAU - Weisenberger, Daniel J AU - Weisenberger DJ FAU - Diefes, Kristin AU - Diefes K FAU - Phillips, Heidi S AU - Phillips HS FAU - Pujara, Kanan AU - Pujara K FAU - Berman, Benjamin P AU - Berman BP FAU - Pan, Fei AU - Pan F FAU - Pelloski, Christopher E AU - Pelloski CE FAU - Sulman, Erik P AU - Sulman EP FAU - Bhat, Krishna P AU - Bhat KP FAU - Verhaak, Roel G W AU - Verhaak RG FAU - Hoadley, Katherine A AU - Hoadley KA FAU - Hayes, D Neil AU - Hayes DN FAU - Perou, Charles M AU - Perou CM FAU - Schmidt, Heather K AU - Schmidt HK FAU - Ding, Li AU - Ding L FAU - Wilson, Richard K AU - Wilson RK FAU - Van Den Berg, David AU - Van Den Berg D FAU - Shen, Hui AU - Shen H FAU - Bengtsson, Henrik AU - Bengtsson H FAU - Neuvial, Pierre AU - Neuvial P FAU - Cope, Leslie M AU - Cope LM FAU - Buckley, Jonathan AU - Buckley J FAU - Herman, James G AU - Herman JG FAU - Baylin, Stephen B AU - Baylin SB FAU - Laird, Peter W AU - Laird PW FAU - Aldape, Kenneth AU - Aldape K CN - Cancer Genome Atlas Research Network LA - eng GR - U24 CA126561-03/CA/NCI NIH HHS/United States GR - U24 CA143882/CA/NCI NIH HHS/United States GR - U24 CA143882-01/CA/NCI NIH HHS/United States GR - P50CA127001/CA/NCI NIH HHS/United States GR - U24 CA126561/CA/NCI NIH HHS/United States GR - P50 CA127001/CA/NCI NIH HHS/United States GR - U24 CA143848/CA/NCI NIH HHS/United States GR - U24 CA126561-03S1/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20100415 PL - United States TA - Cancer Cell JT - Cancer cell JID - 101130617 RN - EC 1.1.1.41 (Isocitrate Dehydrogenase) RN - EC 1.1.1.42. (IDH1 protein, human) SB - IM CIN - Cancer Cell. 2010 May 18;17(5):419-20. PMID: 20478523 MH - Brain Neoplasms/*genetics/pathology MH - *CpG Islands MH - *DNA Methylation MH - Glioblastoma/*genetics/pathology MH - Humans MH - Isocitrate Dehydrogenase/genetics MH - Mutation MH - Phenotype PMC - PMC2872684 MID - NIHMS198493 COIS- Conflict of interest statement P.W.L. is a shareholder, consultant and scientific advisory board member of Epigenomics, AG, which has a commercial interest in DNA methylation markers. This work was not supported by Epigenomics, AG. K.A. is a consultant and scientific advisory board member for Castle Biosciences, which has a commercial interest in molecular diagnostics. This work was not supported by Castle Biosciences. EDAT- 2010/04/20 06:00 MHDA- 2010/06/02 06:00 PMCR- 2011/05/18 CRDT- 2010/04/20 06:00 PHST- 2009/12/08 00:00 [received] PHST- 2010/02/18 00:00 [revised] PHST- 2010/03/30 00:00 [accepted] PHST- 2010/04/20 06:00 [entrez] PHST- 2010/04/20 06:00 [pubmed] PHST- 2010/06/02 06:00 [medline] PHST- 2011/05/18 00:00 [pmc-release] AID - S1535-6108(10)00108-X [pii] AID - 10.1016/j.ccr.2010.03.017 [doi] PST - ppublish SO - Cancer Cell. 2010 May 18;17(5):510-22. doi: 10.1016/j.ccr.2010.03.017. Epub 2010 Apr 15.